Profil
Michael G.
Kelly is currently the Director at Trinds LLC since 2017 and the Chief Scientific Officer at CureDuchenne since 2011.
Previously, he worked as the President, Chief Executive Officer & Director at MyoTherix, Inc. He was also the Research Director at Amgen, Inc. from 1999 to 2000.
Additionally, he worked as a Director at NeoGenesis Pharmaceuticals, Inc. and as the Senior Vice President-Research & Development at Renovis, Inc. Dr. Kelly holds a doctorate degree from The University of Southampton and an undergraduate degree from the University of Ulster.
Aktiva positioner av Michael Kelly
| Företag | Position | Start |
|---|---|---|
CureDuchenne
CureDuchenne Financial ConglomeratesFinance Provides funding for research projects | Teknisk/Vetenskaplig/F&U Direktör | 2011-12-13 |
Trinds LLC
Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases | Direktör/Styrelseledamot | 2017-11-01 |
Tidigare kända positioner av Michael Kelly
| Företag | Position | Slut |
|---|---|---|
| AMGEN INC. | Teknisk/Vetenskaplig/F&U Direktör | 2000-01-01 |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | - |
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Direktör/Styrelseledamot | - |
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Verkställande Direktör | - |
Michael Kellys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Ulster
University of Ulster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance Provides funding for research projects | Finance |
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Health Technology |
Trinds LLC
Trinds LLC Miscellaneous Commercial ServicesCommercial Services Operates as a research organization for neuromuscular diseases | Commercial Services |
















